<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0190877.ref030">
 <label>30</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Burnham</surname>
   <given-names>AJ</given-names>
  </name>, 
  <name>
   <surname>Baranovich</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Marathe</surname>
   <given-names>BM</given-names>
  </name>, 
  <name>
   <surname>Armstrong</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Webster</surname>
   <given-names>RG</given-names>
  </name>, 
  <name>
   <surname>Govorkova</surname>
   <given-names>EA</given-names>
  </name>. 
  <article-title>Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y</article-title>. 
  <source>Antimicrob Agents Chemother</source>. 
  <year>2014</year>; 
  <volume>58</volume>(
  <issue>5</issue>):
  <fpage>2718</fpage>â€“
  <lpage>2730</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.02628-13" xmlns:xlink="http://www.w3.org/1999/xlink">10.1128/AAC.02628-13</ext-link>
  </comment>
  <?supplied-pmid 24566185?>
  <pub-id pub-id-type="pmid">24566185</pub-id>
 </mixed-citation>
</ref>
